Company Filing History:
Years Active: 2006-2007
Title: Innovations in Isoprenoid Production by Markus Hümbelin
Introduction
Markus Hümbelin is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the area of isoprenoid production. With a total of two patents to his name, Hümbelin's work focuses on enhancing the production of valuable compounds through innovative methods.
Latest Patents
Hümbelin's latest patents revolve around the production of isoprenoids. He has developed isolated polynucleotides that encode polypeptides with enzymatic activity in the mevalonate pathway. These sequences are instrumental in the recombinant production of isoprenoid compounds, such as carotenoids, specifically zeaxanthin. His patents also include expression vectors, cultured cells, and methods for synthesizing isoprenoid compounds, showcasing his commitment to advancing biotechnological applications.
Career Highlights
Markus Hümbelin is currently associated with Dsm IP Assets B.V., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in various industries, including pharmaceuticals and agriculture. His expertise in the mevalonate pathway has positioned him as a key figure in the development of sustainable production methods for valuable compounds.
Collaborations
Hümbelin has collaborated with notable colleagues, including Alan Berry and Werner Bretzel. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.
Conclusion
Markus Hümbelin's contributions to isoprenoid production exemplify the intersection of innovation and biotechnology. His patents and ongoing work continue to pave the way for advancements in sustainable production methods.